A groundbreaking study has unveiled a potential game-changer in the fight against Alzheimer's disease. Scientists have ...

KT-621 has demonstrated dupilumab-like activity and was well tolerated ina wide variety of preclinical models of TH2 diseasesKT-621 is expected ...

This is a multicenter, open-label, dose-ranging study with 3 cohorts in the dose-escalation portion assessing safety of OCU200 and in the fourth cohort a combination of OCU200 (MTD) with anti-VEGF ...

Zealand Pharma said it has received a complete response letter from the Food and Drug Administration related to its new drug application for dasiglucagon for the prevention and treatment of ...

Researchers have developed a drug that mimics the effects of exercise. The drug replicates the benefits of running 10km or ...

Aldeyra Therapeutics has resubmitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for topical ...

The FDA decision will enable Antag Therapeutics to initiate the clinical development of its lead candidate drug, a ...

The FDA's Tala Fakhouri discusses the agency's approach to the regulation of AI in clinical trials in a new interview.

A team from the Institute for Molecular Recognition and Technological Development (IDM) at the Universitat Politècnica de ...

French biotech startup Generare has closed a €5 million seed round (around $5.5 million at current exchange rates) to step up ...

With the Oct. 5, 2024 deadline come and gone, th First Foundation received a total of 174 grant applications for programming ...